135 related articles for article (PubMed ID: 4147509)
1. Pilot trials with long-acting pipotiazine injections.
Hakola A
Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
[No Abstract] [Full Text] [Related]
2. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
Elley JH; Petersen JH
Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
[No Abstract] [Full Text] [Related]
4. Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
Robak OH
Acta Psychiatr Scand Suppl; 1973; 241():83-94. PubMed ID: 4147515
[No Abstract] [Full Text] [Related]
5. General evaluation of pipotiazine palmitate (19.552 R.P.) in hospitalized schizophrenic patients.
Gerlach J; Nyeborg O; Prieto R
Acta Psychiatr Scand Suppl; 1973; 241():69-74. PubMed ID: 4147513
[No Abstract] [Full Text] [Related]
6. General evaluation of pipotiazine palmitate in hospitalized and open ward patients with functional psychosis.
Salvesen C; Vaksdal K
Acta Psychiatr Scand Suppl; 1973; 241():57-67. PubMed ID: 4147512
[No Abstract] [Full Text] [Related]
7. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
Dencker SJ; Frankenberg K; Malm U; Zell B
Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
[No Abstract] [Full Text] [Related]
8. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
Salvesen C; Vaksdal K
Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
[No Abstract] [Full Text] [Related]
9. Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigation.
Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
Acta Psychiatr Scand Suppl; 1973; 241():51-6. PubMed ID: 4147511
[No Abstract] [Full Text] [Related]
10. Monthly intermittent chemotherapy of chronic schizophrenic outpatients with pipothiazine palmitate.
Laurent JS; Carle R; Dumais B; Domingue D
Can Psychiatr Assoc J; 1974 Dec; 19(6):583-91. PubMed ID: 4155349
[No Abstract] [Full Text] [Related]
11. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
[No Abstract] [Full Text] [Related]
12. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
Zwanikken GJ
Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
[No Abstract] [Full Text] [Related]
13. Clinical evaluation of a new depot neuroleptic. A pilot study with pipotiazine undecylenate (19.551 R.P.).
Ahlfors UG; Katila O
Acta Psychiatr Scand Suppl; 1973; 241():43-9. PubMed ID: 4147510
[No Abstract] [Full Text] [Related]
14. A study of flupenthixol decanoate and pipotiazine undecylenate in schizophrenics.
Astrup C; Grimgård A; Hebnes K; Kruse-Jensen A; Lid M
Acta Psychiatr Scand; 1974; 50(5):481-91. PubMed ID: 4156624
[No Abstract] [Full Text] [Related]
15. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
[TBL] [Abstract][Full Text] [Related]
16. Fluspirilene, a long-acting injectable neuroleptic.
Ciccarelli G; Nosé F; Zuanazzi GF
Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
[No Abstract] [Full Text] [Related]
17. Review of clinical trials with pipotiazine, pipotiazine undecylenate and pipotiazine palmitate.
Brown-Thomsen J
Acta Psychiatr Scand Suppl; 1973; 241():119-38. PubMed ID: 4151807
[No Abstract] [Full Text] [Related]
18. Uncontrolled study with pipothiazine palmitate.
Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
[No Abstract] [Full Text] [Related]
19. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
Ban TA; Ananth JV; Lehmann HE
Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
[No Abstract] [Full Text] [Related]
20. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
Cassan P
Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
